Furthermore, tumor-infiltrating cDC1s can produce chemokines such as the CXC chemokine ligand (CXCL) 9 and CXCL10 to attract CD8+ T cells into the tumor microenvironment (TME), representing an essential role of DCs for cancer immunotherapy [22]. This evidence concerns the gene CD8A and cancer.